Detoxification of amyloid β fibrils by curcumin derivatives and their verification in a Drosophila Alzheimer's model

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · see citing works

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery

Pandey, U. B., & Nichols, C. D. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003293 · Cited by 1,155 · see citing works

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

Bieschke, J., Russ, J., Friedrich, R., Ehrnhoefer, D. E., Wobst, H. J., Neugebauer, K., & Wanker, E. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0910723107 · Cited by 986 · see citing works

The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds

Hudson, S. A., Ecroyd, H. W., Kee, T. W., & Carver, J. A. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07307.x · Cited by 614 · see citing works

Dietary Curcumin: Correlation between Bioavailability and Health Potential

Dei, M., & Ghidoni, R. (2019) · Nutrients · doi:10.3390/nu11092147 · Cited by 593 · see citing works

Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila : A potential model for Alzheimer's disease

Iijima, K., Liu, H., Chiang, A., Hearn, S., Konsolaki, M., & Zhong, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400895101 · Cited by 482 · see citing works

Drug development in Alzheimer’s disease: the path to 2025

Cummings, J., Aisen, P. S., DuBois, B., Frölich, L., Jack, C. R., Jones, R. W., Morris, J. C., Raskin, J., Dowsett, S. A., & Scheltens, P. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0207-9 · Cited by 459 · see citing works

Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population

Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368 · see citing works

Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial

Small, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L. M., Emerson, N. D., Martinez, J., Wong, K. P., Liu, J., Merrill, D. A., et al. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.10.010 · Cited by 357 · see citing works

Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease

Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F., Gubb, D., & Lomas, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.025 · Cited by 351 · see citing works

A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster

Finelli, A. L., Kelkar, A., Song, H., Yang, H., & Konsolaki, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.001 · Cited by 286 · see citing works

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering

Cummings, J., Aisen, P., Lemere, C., Atri, A., Sabbagh, M., & Salloway, S. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00838-z · Cited by 224 · see citing works

Immunotherapy for Alzheimer’s disease: hoops and hurdles

Lemere, C. A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-36 · Cited by 196 · see citing works

Curcumin Attenuates Amyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway

Thapa, A., Jett, S. D., & Chi, E. Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00214 · Cited by 185 · see citing works

Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease

Ono, K., & Tsuji, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030952 · Cited by 92 · see citing works

Catalytic photooxygenation degrades brain Aβ in vivo

Nagashima, N., Ozawa, S., Furuta, M., Oi, M., Hori, Y., Tomita, T., Sohma, Y., & Kanai, M. (2021) · Science Advances · doi:10.1126/sciadv.abc9750 · Cited by 75 · see citing works

Drosophila Models of Alzheimer's Disease: Advances, Limits, and Perspectives

Bouleau, S., & Tricoire, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142802 · Cited by 69 · see citing works

Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranes

Pithadia, A. S., Bhunia, A., Sribalan, R., Padmini, V., Fierke, C. A., & Ramamoorthy, A. (2015) · Chemical Communications · doi:10.1039/c5cc07792c · Cited by 66 · see citing works

Molecular mechanisms of amyloid disaggregation

Low, K. J. Y., Venkatraman, A., Mehta, J. S., & Pervushin, K. V. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.05.007 · Cited by 48 · see citing works

Development of new fusion proteins for visualizing amyloid-β oligomers in vivo

Ochiishi, T., Doi, M., Yamasaki, K., Hirose, K., Kitamura, A., Urabe, T., Hattori, N., Kinjo, M., Ebihara, T., & Shimura, H. (2016) · Scientific Reports · doi:10.1038/srep22712 · Cited by 46 · see citing works

Genetic Dissection of Alzheimer’s Disease Using Drosophila Models

Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 45 · see citing works

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity

Paul, A., Frenkel‐Pinter, M., Alvarez, D. E., Milordini, G., Gazit, E., Zacco, E., & Segal, D. (2020) · Communications Biology · doi:10.1038/s42003-020-01216-5 · Cited by 42 · see citing works

β‐Amyloid peptide induces formation of actin stress fibers through p38 mitogen‐activated protein kinase

Song, C., Perides, G., Wang, D., & Liu, Y. F. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01182.x · Cited by 41 · see citing works

Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation

Liu, H., Qian, C., Yang, T., Wang, Y., Luo, J. H., Zhang, C., Wang, X., Wang, X., & Guo, Z. (2020) · Chemical Science · doi:10.1039/d0sc00392a · Cited by 41 · see citing works

Sensitivity-Enhanced Solid-State NMR Detection of Structural Differences and Unique Polymorphs in Pico- to Nanomolar Amounts of Brain-Derived and Synthetic 42-Residue Amyloid-β Fibrils

Wickramasinghe, A., Xiao, Y., Kobayashi, N., Wang, S., Scherpelz, K. P., Yamazaki, T., Meredith, S. C., & Ishii, Y. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03346 · Cited by 39 · see citing works

The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

The PROMESA study group, Levin, J., Maaß, S., Schuberth, M., Respondek, G., Paul, F., Mansmann, U., Oertel, W. H., Lorenzl, S., Krismer, F., et al. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1507-8 · Cited by 38 · see citing works

Small molecule induced toxic human-IAPP species characterized by NMR

Cox, S. J., Camargo, D. C. R., Lee, Y., Dubini, R. C. A., Rovó, P., Ivanova, M. I., Padmini, V., Reif, B., & Ramamoorthy, A. (2020) · Chemical Communications · doi:10.1039/d0cc04803h · Cited by 30 · see citing works

Research and standardization in Alzheimer's trials: Reaching international consensus

Carrillo, M. C., Rowe, C. C., Szoeke, C. E. I., Masters, C. L., Ames, D. J., O’Meara, T., Macaulay, S. L., Milner, A., Ellis, K. A., Maruff, P. T., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.10.006 · Cited by 25 · see citing works

Aβ modulates actin cytoskeleton via SHIP2-mediated phosphoinositide metabolism

Lee, H. N., Sim, K. M., Kim, H., Ju, J.-M., Pae, A. N., Park, J., Ryu, H., & Seong, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51914-2 · Cited by 20 · see citing works

Development of curcumin-based amyloid β aggregation inhibitors for Alzheimer's disease using the SAR matrix approach

Utomo, R. Y., Asawa, Y., Okada, S., Ban, H. S., Yoshimori, A., Bajorath, J., & Nakamura, H. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116357 · Cited by 14 · see citing works

Byakangelicin as a modulator for improved distribution and bioactivity of natural compounds and synthetic drugs in the brain

Kang, Y. Y., Song, J., Kim, J. Y., Jung, H., Yeo, W., Lim, Y., & Mok, H. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152963 · Cited by 12 · see citing works

Complementary analysis of curcumin biodistribution using optical fluorescence imaging and mass spectrometry

Kang, Y. Y., Choi, I., Chong, Y., Yeo, W., & Mok, H. (2016) · Applied Biological Chemistry · doi:10.1007/s13765-016-0154-y · Cited by 10 · see citing works

Intranasal Delivery of Pure Nanodrug Loaded Liposomes for Alzheimer's Disease Treatment by Efficiently Regulating Microglial Polarization

Feng, Q., Zhang, X., Zhao, X., Liu, J., Wang, Q., Yao, Y., Xiao, H., Zhu, Y., Zhang, W., & Wang, L. (2024) · Small · doi:10.1002/smll.202405781 · Cited by 95 · see citing works

Curcumin, inflammation, and neurological disorders: How are they linked?

Garodia, P., Hegde, M., Kunnumakkara, A. B., & Aggarwal, B. B. (2023) · Integrative Medicine Research · doi:10.1016/j.imr.2023.100968 · Cited by 73 · see citing works

Natural product-based pharmacological studies for neurological disorders

Puri, V., Kanojia, N., Sharma, A., Huanbutta, K., Dheer, D., & Sangnim, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011740 · Cited by 71 · see citing works

Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights

Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61 · see citing works

Curcumin supplementation increases longevity and antioxidant capacity in Caenorhabditis elegans

Xu, J., Du, P., Liu, X., Xu, X., Ge, Y., & Zhang, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1195490 · Cited by 43 · see citing works

MoS2 quantum dots based on lipid drug delivery system for combined therapy against Alzheimer's disease

Qi, X., Ye, P., & Xie, M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104324 · Cited by 31 · see citing works

Exploring the anti-inflammatory effects of curcumin encapsulated within ferritin nanocages: a comprehensive in vivo and in vitro study in Alzheimer’s disease

Morasso, C., Truffi, M., Tinelli, V., Stivaktakis, P., Gerlando, R. D., Francesca, D., Perini, G., Faisal, M., Aid, J., Noridov, B., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02897-4 · Cited by 21 · see citing works

Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization

Cuccioloni, M., Cecarini, V., Bonfili, L., Pettinari, R., Tombesi, A., Pagliaricci, N., Petetta, L., Angeletti, M., & Eleuteri, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158710 · Cited by 26 · see citing works

Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer’s Disease Patients

Gagliardi, S., Truffi, M., Tinelli, V., Garofalo, M., Pandini, C., Ramusino, M. C., Perini, G., Costa, A. C., Negri, S., Mazzucchelli, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169237 · Cited by 25 · see citing works

An amphiphilic small molecule drives insulin aggregation inhibition and amyloid disintegration

Das, A., Gangarde, Y. M., Pariary, R., Bhunia, A., & Saraogi, I. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.155 · Cited by 24 · see citing works

Curcumin protects PC12 cells from a high glucose-induced inflammatory response by regulating the miR-218-5p/TLR4 axis

Cui, Y., Song, H.-T., Zhang, P., Yin, X., Wang, Y., Wei, X., & Jia, X. (2022) · Medicine · doi:10.1097/md.0000000000030967 · Cited by 12 · see citing works

Bioactive chemicals in Helianthus tuberosus L may reduce beta-amyloid cytotoxicity as a potential novel treatment for Alzheimer's disease

Zhu, W. M., Cadet, P., & Neuwirth, L. S. (2023) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91294-5.00004-x · Cited by 5 · see citing works

Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation

Lestari, B., Utomo, R. Y., Rahman, F. A., Putri, D. D. P., Zulfin, U. M., Suenaga, Y., Meiyanto, E., & Hippo, Y. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05004-8 · Cited by 2 · see citing works

Carboranyl‐Curcuminoids for the Neutron Capture‐Based Treatment of Amyloid Aggregates in Alzheimer's Disease

Micocci, S., Parisotto, S., Alberti, D., Lanfranco, A., Bitonto, V., Renzi, P., Salmi, M., Magnani, A., Bello, F. D., Pagano, K., et al. (2026) · Advanced Science · doi:10.1002/advs.202521701 · Cited by 1 · see citing works

The Effects of Naturally Occurring Phenols on Amyloid Fibrils from Insulin in the Liquid Phase Using Atomic Force Microscopy

Dasani, D. B., Nghiem, T. P., Facteau, K. A., Pollock, C. A., Strain, M., Zuchowski, G. E., & Moriarty, D. F. (2025) · Natural Product Communications · doi:10.1177/1934578x241306603

Development of MRI Probes for Next-Generation Therapeutics and Diagnostics

Okada, S., & NAKAMUIRA, H. (2025) · BUNSEKI KAGAKU · doi:10.2116/bunsekikagaku.74.757

Nose-to-brain delivery of a novel boronated curcuminoid via cyclodextrins: Biodistribution toward potential BNCT applications in Alzheimer's disease

Alberti, D., Micocci, S., Lanfranco, A., Elkhanoufi, S., Bitonto, V., Marcos, J. N. P., Protti, N., Deagostino, A., & Crich, S. G. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115270

Influence of Curcuma longa extract on cognitive function in mild cognitive impairment due to Alzheimer’s disease: a single-arm, open-label, observational study

Manabe, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1951923

Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila

Caesar, I., Jonson, M., Nilsson, K. P. R., Thor, S., & Hammarström, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031424 · Cited by 152 · see citing works

Curcumin alleviates Aβ indcuced neurotoxicity and vice versa without removing amyloid deposits in transgenic Drosophila

Berg, I., Nilsson, K. P. R., Thor, S., & Hammarström, P. (2010)

Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases

Orteca, G., Tavanti, F., Bednáriková, Z., Gažová, Z., Rigillo, G., Imbriano, C., Basile, V., Asti, M., Rigamonti, L., Saladini, M., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.027 · Cited by 33 · see citing works

Proposal of therapeutic curcumin derivatives for Alzheimer’s disease based on ab initio molecular simulations

Shinzato, T., Sato, R., Suzuki, K., Tomioka, S., Sogawa, H., Shulga, S., Blume, Y. B., & Kurita, N. (2019) · Chemical Physics Letters · doi:10.1016/j.cplett.2019.136883 · Cited by 12 · see citing works

Novel curcumin derivatives as potent inhibitors of amyloid β aggregation

Yanagisawa, D., Taguchi, H., Morikawa, S., Kato, T., Hirao, K., Shirai, N., & Tooyama, I. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.10.009 · Cited by 38 · see citing works